Drugs / adipose mesenchymal stem cells
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04351932 Comparator | Jun 2020 → Jun 2021 | osteoarthritis, knee | Universidad Catolica Santiago de Guayaquil | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | adipose mesenchymal stem cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04351932 ↗ |
| Known as | AD-MSC | “Bone marrow mesenchymal stem cells (BM-MSC) and adipose derived mesenchymal stem cells (AD-MSC) have been used separately to treat OA.” NCT04351932 ↗ |
| Modality | Cell therapy | “The purpose of this study was to assess the safety and efficacy of intra-articular injection of autologous adipose tissue derived MSCs (AD-MSCs) for knee osteoarthritis.” PMID 24449146 ↗ May 2014 |